Paper number: CC02 MACRO %NEWFLOW JIAN HUA (DANIEL) HUANG, FOREST LABORATORIES INC, NJ

Size: px
Start display at page:

Download "Paper number: CC02 MACRO %NEWFLOW JIAN HUA (DANIEL) HUANG, FOREST LABORATORIES INC, NJ"

Transcription

1 Paper number: CC02 MACRO %NEWFLOW JIAN HUA (DANIEL) HUANG, FOREST LABORATORIES INC, NJ ABSTRACT: If you use SAS Proc Report frequently, you will be familiar with the flow option. The flow option wraps the value of a character variable in its column, and it honors the split character which is defined in Proc Report. However, the flow option has two limitations. First, it dose not allow you to insert any indent spaces before wrapped lines. Second, if a character variable contains leading blank space, the flow option dose not carry on the leading blank space to wrapped lines. A macro program called %NEWFLOW has been designed to overcome these limitations. In this paper, I will demonstrate the application of %NEWFLOW with examples, discuss the logics of %NEWFLOW with a flowchart, and finally, give the source code of the macro program. BACKGROUND: There are multiple ways to generate a report. Among them, I used proc report procedure a lot. Because I find it is straight forward, dynamic and with many options available. One option called flow is very useful, it wraps the text string in its column and it honors the split character. However, in some cases, flow option dose not work well. For example, if I want to insert certain indent space in the beginning of wrapped lines, or if the original text string contains some leading blank spaces, and I want to carry on the same leading blank spaces to wrapped lines, the flow option itself does not work well. Therefore, I designed a macro program called %NEWFLOW. With the help of %NEWFLOW, the flow option can achieve the new functions by inserting indent spaces or carrying on leading blank spaces into wrapped lines. In next three chapters, I will discuss about the applications, logics and SAS codes of the macro. 1

2 APPLICATION OF %NEWFLOW: The application of %NEWFLOW is demonstrated by examples of AE tables summarized by Body System and Preferred term. The outputs of AE tables, before and after using %NEWFLOW, are listed and compared. Table 1 is a regular AE table output before applying %NEWFLOW. The ID column (the first column in the table) contains the character values of AE terms. Because multiple treatments (treat 1 - treat n) are required in this table, the ID column dose not has enough space to list every AE on one line. Therefore, flow option is called, and some AE with long text strings are wrapped. However, in this typical AE table summarized by two levels of AE terms, the lower level of AE terms (Preferred Terms) contain two leading blank space, when they are wrapped by flow option only, those leading blank spaces can not be carried on to wrapped lines. Table 1. AE tables summarized by SOC and Preferred Terms (Not apply %NEWFLOW macro and ID column without enough spaces) Body System Term Preferred Term Placebo Treat 1 Treat 2... Treat n Patient with at least one TEAE xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Blood and lymphatic system xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) disorders Anaemia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Haemorrhagic anaemia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Leukocytosis xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Neutropenia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiac disorders xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Aortic valve incompetence xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Atrial tachycardia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Atrioventricular block xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) first degree Bundle branch block right xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiac valve sclerosis xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiomyopathy xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Endocarditis noninfective xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve disease xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve incompetence xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve prolapse xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Palpitations xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Postural orthostatic xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) tachycardia syndrome Sinus bradycardia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) 2

3 In order to solve this problem, before using flow option, I apply %NEWFLOW macro on AE result dataset. Calling %NEWFLOW is just as simple as one line SAS statement as below: data result; set result; %Newflow(varin=aeterms, flowlen=30, indent=0, split=%str( )); run; (*Table definition of macro parameters is given later after the source SAS code) Table 2 is the AE table output after applying %NEWFLOW. The leading blank spaces for AE preferred terms are kept in wrapped lines. The output table looks more formal and neat than Table 1. Table 2. AE tables summarized by SOC and Preferred Terms (Apply %NEWFLOW macro: indent space=0) Body System Term Preferred Term Placebo Treat 1 Treat 2... Treat n Patient with at least one TEAE xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Blood and lymphatic system xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) disorders Anaemia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Haemorrhagic anaemia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Leukocytosis xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Neutropenia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiac disorders xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Aortic valve incompetence xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Atrial tachycardia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Atrioventricular block first xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) degree Bundle branch block right xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiac valve sclerosis xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiomyopathy xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Endocarditis noninfective xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve disease xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve incompetence xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve prolapse xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Palpitations xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Postural orthostatic xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) tachycardia syndrome Sinus bradycardia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) 3

4 In addition to keeping the leading blank spaces, %NEWFLOW allows you to add extra indent spaces into wrapped lines. This function is done by defining macro option indent= with number of indent space. data result; set result; %Newflow(varin=aeterms, flowlen=30, indent=1, split=%str( )); run; Table 3 shows the AE output with wrapped lines carrying leading blank space plus one indent space. Please note that one indent space is also applied on the wrapped line for AE Body System term, ie. Blood and lymphatic system disorders. Table 3. AE tables summarized by SOC and Preferred Terms (Apply %NEWFLOW macro: indent space=1) Body System Term Preferred Term Placebo Treatment 1 Treatment 2 Treatment Patient with at least one TEAE xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Blood and lymphatic system xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) disorders Anaemia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Haemorrhagic anaemia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Leukocytosis xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Neutropenia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiac disorders xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Aortic valve incompetence xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Atrial tachycardia xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Atrioventricular block first xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) degree Bundle branch block right xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiac valve sclerosis xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Cardiomyopathy xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Endocarditis noninfective xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve disease xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve incompetence xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Mitral valve prolapse xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Palpitations xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) Postural orthostatic xx(x.x%) xx(x.x%) xx(x.x%) xx(x.x%) tachycardia syndrome 4

5 LOGIC OF %NEWFLOW: The following chart presents the logic of %NEWFLOW macro in 3 steps: Varin= Neoplasms benign, malignant and unspecified (incl cysts and polyps) Step 1, cut input variable into two parts at the last blank space within flow length. Neoplasms benign, malignant and unspecified (incl cysts and polyps) Neoplasms benign, malignant and unspecified (incl cysts and polyps) Step 3, combine every part together as the value of output variable Step 2, add split character on first part, and add leading & indent spaces on remaining part. and unspecified (incl cysts + Repeat step 1&2 on + + and polyps) Varout= Neoplasms benign, malignant and unspecified (incl cysts and polyps) 5

6 SOURCE CODE OF %NEWFLOW: Finally, the SAS source code and variable definition tables are given as below: %Macro newflow (varin=, varout=, flowlen=, indent=0, split=%str( )); %let a_len=%eval(&flowlen+4); length &varout remain temp $500 part $&flowlen apart $&a_len; *-set output variable (varout=) as the same as input variable (varin=) if varout is not specified; %if &varout eq %then %do; %let varout=&varin; % ledspace=length(&varin)-length(left(&varin)) + %eval(&indent); temp=trim(&varin); if length( temp)> &flowlen then do; &varout= " "; exit=100; do i = 1 to exit; if substr( temp,&flowlen,1)=" " or substr( temp,%eval(&flowlen + 1),1)=" " then do; part=substr( temp,1,&flowlen); if length( temp)> &flowlen then do; apart=part "&split"; else do; apart=" " part; if &varout ^= " " then &varout=trim(&varout) trim(apart); else &varout=trim(apart); remain=substr( temp,%eval(&flowlen + 1)); if ledspace =0 then remain=strip(remain); else if ledspace =1 then remain='' strip(remain); else remain=repeat(' ', ledspace-1) strip(remain); else do; endpos=&flowlen - indexc(reverse(substr( temp,1,&flowlen)),''); part=substr( temp,1, endpos); if length( temp)> &flowlen then do; apart=part "&split"; else do; apart=" " part; if &varout ^= " " then &varout=trim(&varout) trim(apart); else &varout=trim(apart); remain=substr( temp, endpos+1); if ledspace =0 then remain=strip(remain); else if ledspace=1 then remain='' strip(remain); else remain=repeat(' ', ledspace-1) strip(remain); temp=remain; if temp=" " then i=exit; %mend newflow; 6

7 Definition table of macro parameters: Parameter definition default value varin list input variable name varin= varout list output variable name (if it is blank, then use the input variable name as varout= the output variable name) flowlen define the length of flow length (shall be less than column length ) flowlen= indent indicate how many indent spaces are given to wrapped lines ( in addition to indent=0 leading blank spaces) split specify the split character (the same split character defined in proc report ) split=%str( ) CONCLUSION: In conclusion, the %NEWFLOW macro allows people to keep the leading blank spaces or add extra indent spaces into wrapped lines. It increases the flexibility of using SAS flow option. The macro itself is simple, straight forward and easy to use. CONTACT INFORMATION: Your comments and questions are valued and encouraged. Please contact the author at: Daniel Huang, MSc, MPH, Forest Research Institute Harborside Financial Center, Plaza V, Jersey City, NJ Tel: Jian.huang@frx.com SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. indicates USA registration. Other brand and product names are registered trademarks or trademarks of their respective companies 7

Kick It Old School - Creating Reports with the DATA _NULL_ Step

Kick It Old School - Creating Reports with the DATA _NULL_ Step Kick It Old School - Creating Reports with the DATA _NULL_ Step Sai Ma, PharmaNet/i3, Toronto, Ontario Canada Suwen Li, Everest Clinical Research Services Inc., Markham, Ontario Canada Minlan Li, Everest

More information

A SAS Macro to Present a Summary Table of the Number of Patients Having Experienced Adverse Events in a Clinical Trial

A SAS Macro to Present a Summary Table of the Number of Patients Having Experienced Adverse Events in a Clinical Trial A SAS Macro to Present a Summary Table of the Number of Patients Having Experienced Adverse Events in a Clinical Trial Christoph Gerlinger * and Ursula Franke ** * Laboratoires Fournier S.C.A. and ** biodat

More information

PROGRAMMER S SAFETY KIT: Important Points to Remember While Programming or Validating Safety Tables

PROGRAMMER S SAFETY KIT: Important Points to Remember While Programming or Validating Safety Tables PharmaSUG 2012 - Paper IB09 PROGRAMMER S SAFETY KIT: Important Points to Remember While Programming or Validating Safety Tables Sneha Sarmukadam, Statistical Programmer, PharmaNet/i3, Pune, India Sandeep

More information

Common Codes for ICD-10

Common Codes for ICD-10 Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified

More information

A DAYS CARDIOVASCULAR UNIT GUIDE DUE WEDNESDAY 4/12

A DAYS CARDIOVASCULAR UNIT GUIDE DUE WEDNESDAY 4/12 A DAYS CARDIOVASCULAR UNIT GUIDE DUE WEDNESDAY 4/12 MONDAY TUESDAY WEDNESDAY THURSDAY FRIDAY 3/20 - B 3/21 - A 3/22 - B 3/23 - A 3/24 - B 3/27 - A Dissection Ethics Debate 3/28 - B 3/29 - A Intro to Cardiovascular

More information

Presented by Sata Hackenbruck 6 August 2009 State of Oregon SAS Users Group Meeting

Presented by Sata Hackenbruck 6 August 2009 State of Oregon SAS Users Group Meeting Presented by Sata Hackenbruck 6 August 2009 State of Oregon SAS Users Group Meeting Explore following SAS text functions: COMPRESS TRANWRD SCAN Here is the problem I am analyzing pharmacy data and I want

More information

Extract Information from Large Database Using SAS Array, PROC FREQ, and SAS Macro

Extract Information from Large Database Using SAS Array, PROC FREQ, and SAS Macro SESUG 2016 Paper CC-160 Extract Information from Large Database Using SAS Array, PROC FREQ, and SAS Macro Lifang Zhang, Department of Biostatistics and Epidemiology, Augusta University ABSTRACT SAS software

More information

Ambulatory Blood Pressure Monitoring

Ambulatory Blood Pressure Monitoring Ambulatory Blood Pressure Monitoring and Devices Chapter.1 Enrollment..................................................................... -2.2 Benefits, Limitations, and Authorization Requirements...........................

More information

A SAS sy Study of ediary Data

A SAS sy Study of ediary Data A SAS sy Study of ediary Data ABSTRACT PharmaSUG 2017 - Paper BB14 A SAS sy Study of ediary Data Amie Bissonett, inventiv Health Clinical, Minneapolis, MN Many sponsors are using electronic diaries (ediaries)

More information

AMBULATORY BLOOD PRESSURE MONITORING AND DEVICES CSHCN SERVICES PROGRAM PROVIDER MANUAL

AMBULATORY BLOOD PRESSURE MONITORING AND DEVICES CSHCN SERVICES PROGRAM PROVIDER MANUAL AMBULATORY BLOOD PRESSURE MONITORING AND DEVICES CSHCN SERVICES PROGRAM PROVIDER MANUAL FEBRUARY 2018 CSHCN PROVIDER PROCEDURES MANUAL FEBRUARY 2018 AMBULATORY B LOOD PRESSURE MONITORING AND DEVICES Table

More information

Systematic Inductive Method for Imputing Partial Missing Dates in Clinical Trials

Systematic Inductive Method for Imputing Partial Missing Dates in Clinical Trials Paper PO05 Systematic Inductive Method for Imputing Partial Missing Dates in Clinical Trials Ping Liu ABSTRACT In any phase of clinical trials, dates are very critical throughout the entire trial. However,

More information

Cardiology/Cardiothoracic

Cardiology/Cardiothoracic Cardiology/Cardiothoracic ICD-9-CM to ICD-10-CM Code Mapper 800-334-5724 www.contexomedia.com 2013 ICD-9-CM 272.0 Pure hypercholesterolemia 272.2 Mixed hyperlipidemia 272.4 Other and hyperlipidemia 278.00

More information

Chapter. CPT only copyright 2010 American Medical Association. All rights reserved. 11Blood Pressure Devices and Supplies

Chapter. CPT only copyright 2010 American Medical Association. All rights reserved. 11Blood Pressure Devices and Supplies 11Blood Pressure Devices and Supplies Chapter 11 11.1 Enrollment..................................................................... 11-2 11.2 Benefits, Limitations, and Authorization Requirements...........................

More information

Matters of the Heart: Comprehensive Cardiology SARAH BEANLANDS RN BSCN MSC

Matters of the Heart: Comprehensive Cardiology SARAH BEANLANDS RN BSCN MSC Matters of the Heart: Comprehensive Cardiology SARAH BEANLANDS RN BSCN MSC Who am I? Class Outline Gross anatomy of the heart Trip around the heart Micro anatomy: cellular and tissue level Introduction

More information

The Heart and Heart Disease

The Heart and Heart Disease The Heart and Heart Disease Illustration of the heart by Leonardo DaVinci heart-surgeon.com/ history.html 2/14/2010 1 I. Location, Size and Position of the Heart A. Triangular organ located 1. of mass

More information

Corlanor. Corlanor (ivabradine) Description

Corlanor. Corlanor (ivabradine) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.05 Subject: Corlanor Page: 1 of 5 Last Review Date: June 24, 2016 Corlanor Description Corlanor (ivabradine)

More information

Appropriate Use Criteria for Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology (scores listed by Appropriate Use rating)

Appropriate Use Criteria for Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology (scores listed by Appropriate Use rating) Appropriate Use Criteria for Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology (scores listed by Appropriate Use rating) Table 1: Appropriate indications (median score 7-9) Indication

More information

Chapter 3 Software Packages to Install How to Set Up Python Eclipse How to Set Up Eclipse... 42

Chapter 3 Software Packages to Install How to Set Up Python Eclipse How to Set Up Eclipse... 42 Table of Contents Preface..... 21 About the Authors... 23 Acknowledgments... 24 How This Book is Organized... 24 Who Should Buy This Book?... 24 Where to Find Answers to Review Questions and Exercises...

More information

PhUSE. PhUSE Computational Science Standard Analyses and Code Sharing Working Group

PhUSE. PhUSE Computational Science Standard Analyses and Code Sharing Working Group PhUSE PhUSE Computational Science Standard Analyses and Working Group Script Discovery and Acquisition Project Team Screen Shots of the Displays Created Using Scripts 1 Table of Contents 1. Disclaimer...

More information

KERN COMMUNITY COLLEGE DISTRICT CERRO COSO COLLEGE HCRS C255 COURSE OUTLINE OF RECORD

KERN COMMUNITY COLLEGE DISTRICT CERRO COSO COLLEGE HCRS C255 COURSE OUTLINE OF RECORD KERN COMMUNITY COLLEGE DISTRICT CERRO COSO COLLEGE HCRS C255 COURSE OUTLINE OF RECORD 1. DISCIPLINE AND COURSE NUMBER: HCRS C255 2. COURSE TITLE: Basic Cardiac Rhythm Interpretation 3. SHORT BANWEB TITLE:

More information

Programmatic Challenges of Dose Tapering Using SAS

Programmatic Challenges of Dose Tapering Using SAS ABSTRACT: Paper 2036-2014 Programmatic Challenges of Dose Tapering Using SAS Iuliana Barbalau, Santen Inc., Emeryville, CA Chen Shi, Santen Inc., Emeryville, CA Yang Yang, Santen Inc., Emeryville, CA In

More information

Pharmaceutical Applications

Pharmaceutical Applications Creating an Input Dataset to Produce Incidence and Exposure Adjusted Special Interest AE's Pushpa Saranadasa, Merck & Co., Inc. Abstract Most adverse event (AE) summary tables display the number of patients

More information

Guideline-Directed Medical Therapy

Guideline-Directed Medical Therapy Guideline-Directed Medical Therapy Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation OPTIMAL THERAPY (As defined in

More information

Creating Multiple Cohorts Using the SAS DATA Step Jonathan Steinberg, Educational Testing Service, Princeton, NJ

Creating Multiple Cohorts Using the SAS DATA Step Jonathan Steinberg, Educational Testing Service, Princeton, NJ Creating Multiple Cohorts Using the SAS DATA Step Jonathan Steinberg, Educational Testing Service, Princeton, NJ ABSTRACT The challenge of creating multiple cohorts of people within a data set, based on

More information

Implementing Worst Rank Imputation Using SAS

Implementing Worst Rank Imputation Using SAS Paper SP12 Implementing Worst Rank Imputation Using SAS Qian Wang, Merck Sharp & Dohme (Europe), Inc., Brussels, Belgium Eric Qi, Merck & Company, Inc., Upper Gwynedd, PA ABSTRACT Classic designs of randomized

More information

ClinialTrials.gov Identifier: sanofi-aventis. Sponsor/company: 07/November/2008

ClinialTrials.gov Identifier: sanofi-aventis. Sponsor/company: 07/November/2008 These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov

More information

Data Analysis and Query Building with MedDRA

Data Analysis and Query Building with MedDRA Data Analysis and Query Building with MedDRA MedDRA was developed under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The

More information

1. The most common extra-intestinal manifestation of inflammatory bowel disease is:

1. The most common extra-intestinal manifestation of inflammatory bowel disease is: ALU 301 Sample Questions 1. The most common extra-intestinal manifestation of inflammatory bowel disease is: 1. uveitis 2. fatty liver 3. arthritis 4. pyoderma gangrenosum 2. Cardiomyopathy characterized

More information

Skin supplied by T1-4 (medial upper arm and neck) T5-9- epigastrium Visceral afferents from skin and heart are the same dorsal root ganglio

Skin supplied by T1-4 (medial upper arm and neck) T5-9- epigastrium Visceral afferents from skin and heart are the same dorsal root ganglio Cardio 2 ECG... 3 Cardiac Remodelling... 11 Valvular Diseases... 13 Hypertension... 18 Aortic Coarctation... 24 Erythropoiesis... 27 Haemostasis... 30 Anaemia... 36 Atherosclerosis... 44 Angina... 48 Myocardial

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Chawla SP, Papai Z, Mukhametshina G, et al. First-line aldoxorubicin vs doxorubicin in metastatic or locally advanced unresectable soft-tissue sarcoma: a phase 2b randomized

More information

Complex Left Atrial (CLA) Best Practices for Navigant

Complex Left Atrial (CLA) Best Practices for Navigant Complex Left Atrial (CLA) Best Practices for Navigant Ischemic Ventricular Tachycardia (VT) Best Practices for Navigant Ischemic VT Ablation Procedures Set Up In the absence of a septal defect or other

More information

Unit 6: Circulatory System. 6.2 Heart

Unit 6: Circulatory System. 6.2 Heart Unit 6: Circulatory System 6.2 Heart Functions of Circulatory System 1. The heart is the pump necessary to circulate blood to all parts of the body 2. Arteries, veins and capillaries are the structures

More information

ECG Analysis and Interpretation Course Table of Contents:

ECG Analysis and Interpretation Course Table of Contents: ECG Analysis and Interpretation Course Table of Contents: Course Outline Overview/Rationale Aims of the Unit Objectives Content Teaching and Learning Methods Assessment Procedures Resources/Mode of Delivery

More information

OCCDS Creating flags or records. Rob Wartenhorst PhUSE Barcelona 2016

OCCDS Creating flags or records. Rob Wartenhorst PhUSE Barcelona 2016 OCCDS Creating flags or records Rob Wartenhorst PhUSE Barcelona 2016 Introduction ADAE, ADCM and ADMH originally set up using ADAE structure. After release of OCCDS guide attempted to implement the occurrence

More information

Review Questions in Introductory Knowledge... 37

Review Questions in Introductory Knowledge... 37 Table of Contents Preface..... 17 About the Authors... 19 How This Book is Organized... 20 Who Should Buy This Book?... 20 Where to Find Answers to Review Questions and Exercises... 20 How to Report Errata...

More information

Methodology for Non-Randomized Clinical Trials: Propensity Score Analysis Dan Conroy, Ph.D., inventiv Health, Burlington, MA

Methodology for Non-Randomized Clinical Trials: Propensity Score Analysis Dan Conroy, Ph.D., inventiv Health, Burlington, MA PharmaSUG 2014 - Paper SP08 Methodology for Non-Randomized Clinical Trials: Propensity Score Analysis Dan Conroy, Ph.D., inventiv Health, Burlington, MA ABSTRACT Randomized clinical trials serve as the

More information

Cardiac Dysrhythmias and Sports

Cardiac Dysrhythmias and Sports Sudden unexpected death during athletic participation is the overriding consideration in advising individuals with dysrhythmias about participation in sports. The incidence of sudden death is 1 to 2 per

More information

Cardiac Examination. Pediatrics Clinical Examination

Cardiac Examination. Pediatrics Clinical Examination Pediatrics Clinical Examination Symptoms of Cardiovascular Affection: Cardiac Examination 1. Perinatal history: Maternal DM, cyanosis, respiratory distress 2. Symptoms of lung congestion: Poor interrupted

More information

Full Novartis CTRD Results Template

Full Novartis CTRD Results Template Full Novartis CTRD Results Template Sponsor Novartis Generic Drug Name vildagliptin Therapeutic Area of Trial Type 2 diabetes Approved Indication Type 2 diabetes Protocol Number CLAF237A23137E1 Title A

More information

Case # 1. Page: 8. DUKE: Adams

Case # 1. Page: 8. DUKE: Adams Case # 1 Page: 8 1. The cardiac output in this patient is reduced because of: O a) tamponade physiology O b) restrictive physiology O c) coronary artery disease O d) left bundle branch block Page: 8 1.

More information

Classification of Neoplasms

Classification of Neoplasms Classification of Neoplasms ICD-10 Chapter 2, Neoplasms Codes C00-D48 Notes at beginning of Chapter 2 Classified by behaviour and site Correct use of Alphabetic index required Main terms Modifiers Table

More information

ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: 01/19/2016. ClinicalTrials.gov ID: NCT

ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: 01/19/2016. ClinicalTrials.gov ID: NCT ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: 01/19/2016 ClinicalTrials.gov ID: NCT00595413 Study Identification Unique Protocol ID: 27905 Brief Title: Atacicept

More information

Imputing Dose Levels for Adverse Events

Imputing Dose Levels for Adverse Events Paper HO03 Imputing Dose Levels for Adverse Events John R Gerlach & Igor Kolodezh CSG Inc., Raleigh, NC USA ABSTRACT Besides the standard reporting of adverse events in clinical trials, there is a growing

More information

current, and acting like

current, and acting like Heart 10 IV. HEART PHYSIOLOGY - How the heart beats. How the heart depolarizes the myocardium, which leads to a contraction. A) INTRINSIC CONTROL - Heart controls its own rhythm. HOW? The presence of gap

More information

ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: 10/11/2013. ClinicalTrials.gov ID: NCT

ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: 10/11/2013. ClinicalTrials.gov ID: NCT ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: 10/11/2013 ClinicalTrials.gov ID: NCT00168454 Study Identification Unique Protocol ID: 191622-077 Brief Title: A

More information

CMS Limitations Guide - Radiology Services

CMS Limitations Guide - Radiology Services CMS Limitations Guide - Radiology Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations

More information

The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not

The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Bio 104 Cardiovascular System

Bio 104 Cardiovascular System 29 Blood: Introduction (Chapter 14) A. Characteristics of Blood 1. Blood Volume Lecture Outline: Cardiovascular System Hole s HAP [Chapters 14, 15, 16] 2. Blood Composition a. Blood Cells Red blood cells

More information

Generate Informative Clinical Laboratory Results Listing

Generate Informative Clinical Laboratory Results Listing PharmaSUG2011 - Paper PO02 Generate Informative Clinical Laboratory Results Listing Sai Ma, Everest Clinical Research Services Inc., Markham, Ontario Canada ABSTRACT Clinical laboratory results review

More information

Study No.: Title: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study No.: Title: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Cardiology Competency Based Goals and Objectives

Cardiology Competency Based Goals and Objectives Cardiology Competency Based Goals and Objectives COMPETENCY 1. Patient Care. Provide family centered patient care that is developmentally and age appropriate, compassionate, and effective for the treatment

More information

A SAS Macro to Investigate Statistical Power in Meta-analysis Jin Liu, Fan Pan University of South Carolina Columbia

A SAS Macro to Investigate Statistical Power in Meta-analysis Jin Liu, Fan Pan University of South Carolina Columbia Paper 109 A SAS Macro to Investigate Statistical Power in Meta-analysis Jin Liu, Fan Pan University of South Carolina Columbia ABSTRACT Meta-analysis is a quantitative review method, which synthesizes

More information

Data Analysis and Query Building with MedDRA

Data Analysis and Query Building with MedDRA Data Analysis and Query Building with MedDRA MedDRA was developed under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The

More information

IB TOPIC 6.2 THE BLOOD SYSTEM

IB TOPIC 6.2 THE BLOOD SYSTEM IB TOPIC 6.2 THE BLOOD SYSTEM THE BLOOD SYSTEM TERMS TO KNOW circulation ventricle artery vein 6.2.U1 - Arteries convey blood at high pressure from the ventricles to the tissues of the body Circulation

More information

Electrical System Overview Electrocardiograms Action Potentials 12-Lead Positioning Values To Memorize Calculating Rates

Electrical System Overview Electrocardiograms Action Potentials 12-Lead Positioning Values To Memorize Calculating Rates Electrocardiograms Electrical System Overview James Lamberg 2/ 74 Action Potentials 12-Lead Positioning 3/ 74 4/ 74 Values To Memorize Inherent Rates SA: 60 to 100 AV: 40 to 60 Ventricles: 20 to 40 Normal

More information

Cardiovascular System

Cardiovascular System Cardiovascular System angio BELLWORK Day One: Define using technology hemo/hema cardio Medical Therapeutics Standards 11) Outline the gross normal structure and function of all body systems and summarize

More information

Using Direct Standardization SAS Macro for a Valid Comparison in Observational Studies

Using Direct Standardization SAS Macro for a Valid Comparison in Observational Studies T07-2008 Using Direct Standardization SAS Macro for a Valid Comparison in Observational Studies Daojun Mo 1, Xia Li 2 and Alan Zimmermann 1 1 Eli Lilly and Company, Indianapolis, IN 2 inventiv Clinical

More information

Cardiac Telemetry Self Study: Part One Cardiovascular Review 2017 THINGS TO REMEMBER

Cardiac Telemetry Self Study: Part One Cardiovascular Review 2017 THINGS TO REMEMBER Please review the above anatomy of the heart. THINGS TO REMEMBER There are 3 electrolytes that affect cardiac function o Sodium, Potassium, and Calcium When any of these electrolytes are out of the normal

More information

Congenital heart disease. By Dr Saima Ali Professor of pediatrics

Congenital heart disease. By Dr Saima Ali Professor of pediatrics Congenital heart disease By Dr Saima Ali Professor of pediatrics What is the most striking clinical finding in this child? Learning objectives By the end of this lecture, final year student should be able

More information

Lab 8: Multiple Linear Regression

Lab 8: Multiple Linear Regression Lab 8: Multiple Linear Regression 1 Grading the Professor Many college courses conclude by giving students the opportunity to evaluate the course and the instructor anonymously. However, the use of these

More information

Combining Electronic Diary Seizure Data with Visit-Based Seizure Data in the MONEAD Study

Combining Electronic Diary Seizure Data with Visit-Based Seizure Data in the MONEAD Study PharmaSUG 2018 - Paper RW-02 Combining Electronic Diary Seizure Data with Visit-Based Seizure Data in the MONEAD Study Julia Skinner and Ryan May, Emmes Corporation ABSTRACT Electronic diary (ediary) mobile

More information

ADaM Tips for Exposure Summary

ADaM Tips for Exposure Summary ABSTRACT PharmaSUG China 2016 Paper 84 ADaM Tips for Exposure Summary Kriss Harris, SAS Specialists Limited, Hertfordshire, United Kingdom Have you ever created the Analysis Dataset for the Exposure Summary

More information

PATIENT WITH ARRHYTHMIA IN DENTIST S OFFICE. Małgorzata Kurpesa, MD., PhD. Chair&Department of Cardiology

PATIENT WITH ARRHYTHMIA IN DENTIST S OFFICE. Małgorzata Kurpesa, MD., PhD. Chair&Department of Cardiology PATIENT WITH ARRHYTHMIA IN DENTIST S OFFICE Małgorzata Kurpesa, MD., PhD. Chair&Department of Cardiology Medical University of Łódź The heart is made up of four chambers Left Atrium Right Atrium Left Ventricle

More information

Intro to SPSS. Using SPSS through WebFAS

Intro to SPSS. Using SPSS through WebFAS Intro to SPSS Using SPSS through WebFAS http://www.yorku.ca/computing/students/labs/webfas/ Try it early (make sure it works from your computer) If you need help contact UIT Client Services Voice: 416-736-5800

More information

Figure ) The specific chamber of the heart that is indicated by letter A is called the. Diff: 1 Page Ref: 364

Figure ) The specific chamber of the heart that is indicated by letter A is called the. Diff: 1 Page Ref: 364 Essentials of Anatomy and Physiology, 9e (Marieb) Chapter 11 The Cardiovascular System Short Answer Figure 11.1 Using Figure 11.1, identify the following: 1) The Purkinje fibers are indicated by label.

More information

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia Supplementary Table S1 International Classification of Disease 10 (ICD-10) codes Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care I48 AF

More information

CMS Limitations Guide - Cardiovascular Services

CMS Limitations Guide - Cardiovascular Services CMS Limitations Guide - Cardiovascular Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations

More information

Knowledge is Power: The Basics of SAS Proc Power

Knowledge is Power: The Basics of SAS Proc Power ABSTRACT Knowledge is Power: The Basics of SAS Proc Power Elaina Gates, California Polytechnic State University, San Luis Obispo There are many statistics applications where it is important to understand

More information

Collapsing Longitudinal Data Across Related Events and Imputing Endpoints

Collapsing Longitudinal Data Across Related Events and Imputing Endpoints Collapsing Longitudinal Data Across Related Events and Imputing Endpoints James Joseph, INC Research, King of Prussia, PA INTRODUCTION When attempting to answer a research question, the best study design

More information

The Cardiovascular System

The Cardiovascular System C H A P T E R 1 4 The Cardiovascular System OBJECTIVES After studying this chapter, you should be able to: 1. Describe how the heart is positioned in the thoracic cavity. 2. List and describe the layers

More information

The Cardiovascular System

The Cardiovascular System PowerPoint Lecture Slide Presentation by Patty Bostwick-Taylor, Florence-Darlington Technical College The Cardiovascular System 11 PART A The Cardiovascular System A closed system of the heart and blood

More information

4. The two inferior chambers of the heart are known as the atria. the superior and inferior vena cava, which empty into the left atrium.

4. The two inferior chambers of the heart are known as the atria. the superior and inferior vena cava, which empty into the left atrium. Answer each statement true or false. If the statement is false, change the underlined word to make it true. 1. The heart is located approximately between the second and fifth ribs and posterior to the

More information

Diseases of the Conduction System

Diseases of the Conduction System 4 CHAPTER 4 Diseases of the Conduction System Diseases of the conduction system are numerous and varied. The authors have selected a few representative entities for this section: complete heart block as

More information

Gloucester City Council

Gloucester City Council Gloucester City Council Medical Examination Report To be filled in by the Doctor. The Patient must fill in sections 9 and 10 in the doctor s presence (please use black ink) Before filling in this form,

More information

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview Pediatrics Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment See online here The most common form of cardiac arrhythmia in children is sinus tachycardia which can be caused by

More information

BME 5742 Bio-Systems Modeling and Control. Lecture 41 Heart & Blood Circulation Heart Function Basics

BME 5742 Bio-Systems Modeling and Control. Lecture 41 Heart & Blood Circulation Heart Function Basics BME 5742 Bio-Systems Modeling and Control Lecture 41 Heart & Blood Circulation Heart Function Basics Dr. Zvi Roth (FAU) 1 Pumps A pump is a device that accepts fluid at a low pressure P 1 and outputs the

More information

The production of murmurs is due to 3 main factors:

The production of murmurs is due to 3 main factors: Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or

More information

Sponsor. Generic Drug Name. Trial Indications. Protocol Number. Protocol Title. Clinical Trial Phase. Study Start/End Dates. Reason for Termination

Sponsor. Generic Drug Name. Trial Indications. Protocol Number. Protocol Title. Clinical Trial Phase. Study Start/End Dates. Reason for Termination Sponsor Alcon Research, Ltd. Generic Drug Name Travoprost/timolol maleate Trial Indications Open-angle glaucoma or ocular hypertension Protocol Number C-09-007 Protocol Title An Evaluation of Patient Reported

More information

4Stat Wk 10: Regression

4Stat Wk 10: Regression 4Stat 342 - Wk 10: Regression Loading data with datalines Regression (Proc glm) - with interactions - with polynomial terms - with categorical variables (Proc glmselect) - with model selection (this is

More information

The production of murmurs is due to 3 main factors:

The production of murmurs is due to 3 main factors: Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or

More information

Graph Display of Patient Profile Using SAS

Graph Display of Patient Profile Using SAS PharmaSUG 2018 - Paper DV-17 Graph Display of Patient Profile Using SAS Yanwei Han, Seqirus USA Inc., Cambridge, MA Hongyu Liu, Seqirus USA Inc., Cambridge, MA ABSTRACT We usually create patient profile

More information

(2) (1) (3) (4) BLOOD PATHWAY ASSESSMENT RUBRIC

(2) (1) (3) (4) BLOOD PATHWAY ASSESSMENT RUBRIC BLOODPATHWAYASSESSMENT(4) BLOOD%PATHWAY%ASSESSMENT%(3)% BLOODPATHWAYASSESSMENT(3) (4) (3) (2) (1) Using a completely blank diagram of the heart, all valves, chambers, great vessels, and direction of blood

More information

AE: An Essential Part of Safety Summary Table Creation. Rucha Landge, Inventiv International Pharma Services Pvt. Ltd.

AE: An Essential Part of Safety Summary Table Creation. Rucha Landge, Inventiv International Pharma Services Pvt. Ltd. PharmaSUG 2016 - Paper IB11 AE: An Essential Part of Safety Summary Table Creation. Rucha Landge, Inventiv International Pharma Services Pvt. Ltd., Pune, India ABSTRACT Adverse event (AE) summary tables

More information

The Cardiovascular System

The Cardiovascular System Essentials of Human Anatomy & Physiology Elaine N. Marieb Slides 11.1 11.19 Seventh Edition Chapter 11 The Cardiovascular System Functions of the Cardiovascular system Function of the heart: to pump blood

More information

Home Health Prospective Payment System. Overview

Home Health Prospective Payment System. Overview Overview Version 6117 January 2017 PBL-046 Java is a registered trademark of Oracle and/or its affiliates. Table of Contents Overview of the... 5 Background and versioning... 5 Changes for this version...

More information

JUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012

JUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012 SAMUEL TCHWENKO, MD, MPH Epidemiologist, Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section; Division of Public Health NC Department of Health & Human Services JUSTUS WARREN TASK

More information

Cardiac Implanted Electronic Devices Pacemakers, Defibrillators, Cardiac Resynchronization Devices, Loop Recorders, etc.

Cardiac Implanted Electronic Devices Pacemakers, Defibrillators, Cardiac Resynchronization Devices, Loop Recorders, etc. Cardiac Implanted Electronic Devices Pacemakers, Defibrillators, Cardiac Resynchronization Devices, Loop Recorders, etc. The Miracle of Living February 21, 2018 Matthew Ostrom MD,FACC,FHRS Division of

More information

CARDIOVASCULAR DISEASE Maintenance of Certification (MOC) Examination Blueprint

CARDIOVASCULAR DISEASE Maintenance of Certification (MOC) Examination Blueprint CARDIOVASCULAR DISEASE Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Cardiovascular Disease MOC exam blueprint Based on feedback from physicians that

More information

ADVANCED VBA FOR PROJECT FINANCE Near Future Ltd. Registration no

ADVANCED VBA FOR PROJECT FINANCE Near Future Ltd. Registration no ADVANCED VBA FOR PROJECT FINANCE f i n a n c i a l f o r e c a s t i n G 2017 Near Future Ltd. Registration no. 10321258 www.nearfuturefinance.com info@nearfuturefinance.com COURSE OVERVIEW This course

More information

ENROLLMENT : Line of Business Summary

ENROLLMENT : Line of Business Summary ENROLLMENT : Line of Business Summary Date Range : JAN 2017 through DEC 2017 COMPREHENSIVE MAJOR MEDICAL Print Date : 1/19/2018 9:43:49AM Page 1 of 1 Month Year Single 2 Person : Emp/Spouse 2 Person :

More information

A Comparison of Linear Mixed Models to Generalized Linear Mixed Models: A Look at the Benefits of Physical Rehabilitation in Cardiopulmonary Patients

A Comparison of Linear Mixed Models to Generalized Linear Mixed Models: A Look at the Benefits of Physical Rehabilitation in Cardiopulmonary Patients Paper PH400 A Comparison of Linear Mixed Models to Generalized Linear Mixed Models: A Look at the Benefits of Physical Rehabilitation in Cardiopulmonary Patients Jennifer Ferrell, University of Louisville,

More information

NDoc Reference for the July 2012 Patient Demographic Enhancements

NDoc Reference for the July 2012 Patient Demographic Enhancements Summary: This document provides a summary of the patient demographic enhancements incorporated in the July 2012 Update, including changes to the entry of patient names, the charting of patient address

More information

ACLS Study Guide for Precourse Self-Assessment

ACLS Study Guide for Precourse Self-Assessment 20 rhythm strips on Precourse Self-Assessment with the following matching choices: Agonal Rhythm/Asystole Atrial Fibrillation Flutter Ventricular Fibrillation Monomorphic Ventricular Normal Sinus Rhythm

More information

Graduate Certificate in Electrocardiograph (ECG) Interpretation. Code 10447NAT

Graduate Certificate in Electrocardiograph (ECG) Interpretation. Code 10447NAT Graduate Certificate in Electrocardiograph (ECG) Code 10447NAT On behalf of The Benchmarque Group, I am delighted to introduce you to our Graduate Certificate in Electrocardiograph (ECG). This self directed

More information

Principles of Biomedical Systems & Devices. Lecture 8: Cardiovascular Dynamics Dr. Maria Tahamont

Principles of Biomedical Systems & Devices. Lecture 8: Cardiovascular Dynamics Dr. Maria Tahamont Principles of Biomedical Systems & Devices Lecture 8: Cardiovascular Dynamics Dr. Maria Tahamont Review of Cardiac Anatomy Four chambers Two atria-receive blood from the vena cave and pulmonary veins Two

More information

Anatomy lab -1- Imp note: papillary muscle Trabeculae Carneae chordae tendineae

Anatomy lab -1- Imp note: papillary muscle Trabeculae Carneae chordae tendineae Anatomy lab -1- Imp note: the arrangement of this sheet is different than the lab recording, it has been arranged in a certain way to make it easier to study. When you open the left ventricle you can see

More information

2.1 Numerator: The number of denominator continuous inpatient spells (i.e. spells excluding those with a diagnosis

2.1 Numerator: The number of denominator continuous inpatient spells (i.e. spells excluding those with a diagnosis 2) Hospital case-fatality 2.1 Numerator: The number of denominator continuous inpatient spells (i.e. spells excluding those with a diagnosis of cancer anywhere in the spell) where the patient dies in hospital

More information

: Provide cardiovascular preventive counseling to parents and patients with specific cardiac diseases about:

: Provide cardiovascular preventive counseling to parents and patients with specific cardiac diseases about: Children s Hospital & Research Center Oakland Cardiology Primary Goals for this Rotation 5.13 GOAL: Prevention, Counseling and Screening (Cardiovascular). Understand the role of the pediatrician in preventing

More information